VS
stockvs
Go to ScreenerHub
JNJ

JNJ vs PFE

PFE

In the past 12 months, JNJ returned +49% while PFE gained 2%.

JNJ
JNJ

Johnson & Johnson

$243.19
-0.1%(1M)
Market Cap586.1B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio22.08
ROE33.8%
P/B Ratio7.26
Dividend Yield2.1%
PFE
PFE

Pfizer Inc.

$26.61
-2.8%(1M)
Market Cap151.3B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio19.86
ROE8.7%
P/B Ratio1.78
Dividend Yield6.3%
Performance Comparison

Historical returns across multiple timeframes

JNJ leads 8/8
JNJ

JNJ

Johnson & Johnson

+49.3%

1Y Return

PFE

PFE

Pfizer Inc.

+2.1%

1Y Return

JNJ
JNJ
PFE
PFE

Short Term

1M-6M

JNJ
+18.0%

Medium Term

YTD-1Y

JNJ
+33.3%

Long Term

3Y-10Y

JNJ
+78.3%

Valuation

Compare price multiples and valuation ratios

JNJ: 0PFE: 5
MetricJNJPFEWinner
P/E Ratio

Price to earnings ratio

22.0819.86PFE
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

6.242.47PFE
P/B Ratio

Price to book ratio

7.261.78PFE
P/FCF Ratio

Price to free cash flow ratio

29.8217.02PFE
EV/EBITDA

Enterprise value to EBITDA

15.3613.16PFE
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

JNJ: 6PFE: 0
MetricJNJPFEWinner
Gross Margin

Gross profit margin

72.8%70.3%JNJ
Operating Margin

Operating profit margin

27.2%24.7%JNJ
Net Margin

Net profit margin

28.5%12.4%JNJ
ROE

Return on equity

33.8%8.7%JNJ
ROA

Return on assets

13.5%3.7%JNJ
ROIC

Return on invested capital

13.7%8.8%JNJ

Growth

Compare revenue and earnings growth rates

JNJ: 5PFE: 1
MetricJNJPFEWinner
Revenue Growth (YoY)

Year-over-year revenue growth

6.0%-1.6%JNJ
Revenue Growth (3Y)

3-year revenue CAGR

5.6%-14.6%JNJ
Revenue Growth (5Y)

5-year revenue CAGR

2.7%8.5%PFE
EPS Growth (YoY)

Year-over-year EPS growth

90.5%-3.5%JNJ
EPS Growth (3Y)

3-year EPS CAGR

17.9%-37.1%JNJ
EPS Growth (5Y)

5-year EPS CAGR

14.9%-3.5%JNJ

Balance Sheet & Risk

Compare financial stability and debt levels

JNJ: 3PFE: 2
MetricJNJPFEWinner
Debt/Equity

Debt to equity ratio

0.590.78JNJ
Current Ratio

Current assets to current liabilities

1.031.16PFE
Quick Ratio

Quick assets to current liabilities

0.770.87PFE
Interest Coverage

EBIT to interest expense

26.365.78JNJ
Beta

Stock volatility vs market

0.330.41JNJ
Summary
JNJ wins 3-1

Valuation

PFE

Profitability

JNJ

Growth

JNJ

Balance Sheet

JNJ

PFE is more attractively valued. JNJ shows stronger profitability. JNJ demonstrates better growth. JNJ has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into JNJ and PFE with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/JNJ/vs/PFE" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare JNJ vs PFE on stockvs.app
</a>